{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:06:46Z","timestamp":1790057206094,"version":"4.0.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>GCA is a large vessel vasculitis for which triggering factors remain unknown. Clonal haematopoiesis (CH) was associated with atherosclerosis through the induction of inflammation in myeloid cells, and data suggest that CH expansion and inflammation may support each other to induce a pro-inflammatory loop. Our objective was to describe the impact of JAK2p.V617F-mutated myeloproliferative neoplasms (MPNs) on GCA and to screen MPN-free patients for CH mutations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective case\u2013control study comparing the characteristics of 21 GCA patients with MPN and 42 age- and gender-matched GCA patients without MPN. Also, 18 GCA patients were screened for CH through next-generation sequencing (NGS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The most frequent associated MPN was essential thrombocythaemia (ET; n\u2009=\u200911). Compared with controls, GCA patients with MPN had less-frequent cephalic symptoms (71.4 vs 97.6%; P\u2009=\u20090.004) and higher platelet counts at baseline [485\u2009\u00d7\u2009109\/l (interquartile range 346\u2013586) vs 346 (296\u2013418); P\u2009=\u20090.02]. There was no difference between groups for other clinical features. Overall survival was significantly shorter in patients with MPN compared with controls [hazard ratio 8.2 (95% CI 1.2, 56.6); P\u2009=\u20090.03]. Finally, screening for CH using NGS in 15 GCA patients without MPN revealed CH in 33%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>GCA patients with MPN display higher platelet counts and shorter overall survival than controls. This association is not fortuitous, given the possible pathophysiological relationship between the two diseases. CH was found in one-third of GCA patients, which may be higher than the expected prevalence for a similar age, and should be confirmed in a larger cohort.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab337","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T11:18:22Z","timestamp":1617880702000},"page":"775-780","source":"Crossref","is-referenced-by-count":21,"title":["Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case\u2013control and exploratory study"],"prefix":"10.1093","volume":"61","author":[{"given":"Matthias","family":"Papo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Friedrich","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Cochin Institute, Paris University, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Delaval","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-8365","authenticated-orcid":false,"given":"Hubert de","family":"Boysson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, UNICAEN, EA4650 SEILIRM, Caen Normandie University Hospital, Caen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Viallard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Infectious Diseases, Haut L\u00e9v\u00eaque University Hospital, Bordeaux University, Pessac"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Bachmeyer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, AP-HP, Tenon Hospital, Sorbonne University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-2537","authenticated-orcid":false,"given":"Thomas","family":"Sen\u00e9","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rothschild Foundation Hospital, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Humbert","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, University Hospital Besancon, Besan\u00e7on"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Saint Andre Hospital, University Hospital Centre of Bordeaux"},{"name":"CNRS UMR 5164, Immuno ConcEpT, Bordeaux University, Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Contis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Saint Andre Hospital, University Hospital Centre of Bordeaux"},{"name":"CNRS UMR 5164, Immuno ConcEpT, Bordeaux University, Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Agard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU Nantes, Nantes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gombert","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, La Rochelle Hospital, La Rochelle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-0138","authenticated-orcid":false,"given":"Mathieu","family":"Puyade","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Infectious Diseases, Poitiers Universitary Hospital, Poitiers"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Foucher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU de La R\u00e9union, Saint Pierre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Alary","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Cochin Institute, Paris University, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Danlos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"R\u00e9gent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Samson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Fran\u00e7ois-Mitterrand Teaching Hospital, University of Bourgogne-Franche-Comt\u00e9, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Cochin Institute, Paris University, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the French Vasculitis Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"2022020819080429100_keab337-B1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2022020819080429100_keab337-B2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"2022020819080429100_keab337-B3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.autrev.2017.05.004","article-title":"New insights into the pathogenesis of giant cell arteritis","volume":"16","author":"Ciccia","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2022020819080429100_keab337-B4","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"2022020819080429100_keab337-B5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"2022020819080429100_keab337-B6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"2022020819080429100_keab337-B7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587089","article-title":"Cellular signaling pathways in medium and large vessel vasculitis","author":"Watanabe","year":"2020","journal-title":"Front Immunol"},{"key":"2022020819080429100_keab337-B8","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"2022020819080429100_keab337-B9","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"2022020819080429100_keab337-B10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s100670200081","article-title":"Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?","volume":"21","author":"Espinosa","year":"2002","journal-title":"Clin Rheumatol"},{"key":"2022020819080429100_keab337-B11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S0755-4982(04)98914-2","article-title":"Disease associations in 250 patients with temporal (giant cell) arteritis","volume":"33","author":"Liozon","year":"2004","journal-title":"Presse Med"},{"key":"2022020819080429100_keab337-B12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/039463201002300433","article-title":"Severe giant cell arteritis associated with essential thrombocythaemia","volume":"23","author":"Montalto","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2022020819080429100_keab337-B13","doi-asserted-by":"crossref","first-page":"102446","DOI":"10.1016\/j.autrev.2019.102446","article-title":"Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review","volume":"19","author":"Roupie","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2022020819080429100_keab337-B14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"2022020819080429100_keab337-B15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","article-title":"Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation","volume":"37","author":"Frick","year":"2019","journal-title":"J Clin Oncol"},{"key":"2022020819080429100_keab337-B16","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/rheumatology\/keaa282","article-title":"Clonal haematopoiesis is increased in early onset in systemic sclerosis","volume":"59","author":"Ricard","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab337\/38388867\/keab337.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/775\/42368682\/keab337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/775\/42368682\/keab337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T19:09:13Z","timestamp":1644347353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/2\/775\/6219309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,9]]},"published-print":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab337","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,4,9]]}}}